Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
about
SUMOylation-Mediated Regulation of Cell Cycle Progression and CancerNeuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories.Characterization of a novel posttranslational modification in polypyrimidine tract-binding proteins by SUMO1.Parental binge alcohol abuse alters F1 generation hypothalamic gene expression in the absence of direct fetal alcohol exposure.SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.The role of ubiquitin-proteasome system in glioma survival and growth.SUMO rules: regulatory concepts and their implication in neurologic functions.SUMO pathway components as possible cancer biomarkers.SUMO-1 Gene Silencing Inhibits Proliferation and Promotes Apoptosis of Human Gastric Cancer SGC-7901 Cells.Neuron-specific SUMO knockdown suppresses global gene expression response and worsens functional outcome after transient forebrain ischemia in mice.SUMO and the robustness of cancer.Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells.Targeting the SUMO pathway for neuroprotection in brain ischaemia.SUMOylation in brain ischemia: Patterns, targets, and translational implications.The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis.
P2860
Q26776081-2225FA97-5860-4FCA-871B-6C7635AE6DBDQ30434696-7D998E7F-DCC1-4884-8862-FA6A126F2FEAQ34180088-88CBC6E4-064D-4C72-9FC5-CE72A9C3BE21Q35107054-B272ED6A-C494-4386-BCB4-DDD079156EDCQ35245641-878F3C56-7A55-4B78-898A-D8390CA7C538Q35388346-3A8DF47F-D3B4-402E-99EA-A23657AD932FQ36295602-EFE2C6CF-8F9F-41CE-A01F-EDB77043B05CQ38107999-F3278E0E-B9D0-48A6-A90F-6E3CC96F1E14Q38132691-A3E952A9-9ADE-48BD-9A94-E9AEA688B243Q38515816-224843D9-6F43-461B-B70E-8B8E0E7C9051Q38715505-7E233709-EB51-4A3C-A948-15D6B718CD29Q38786900-9EE19FAF-8576-4583-AE0A-90C8089B7517Q39108925-36F415CD-6049-4050-8BD9-4CAE6E051E76Q41287854-8290C91D-9EF6-4C34-95A9-C713BBF2A3F9Q41620482-A4FC4E00-FE1A-48EB-B81E-D5395F4633F3Q41678635-7BB73B4F-C3DF-418E-8A4F-B200B5452535Q47392649-85F067CC-7FC8-469F-89FF-FE1598D36A98Q55514789-88FFCD8A-4A14-4EFA-AE0E-C2EEEDF60DCB
P2860
Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@ast
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@en
type
label
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@ast
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@en
prefLabel
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@ast
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@en
P2093
P2860
P356
P1433
P1476
Small ubiquitin-like modifier ...... or glioblastoma cell survival.
@en
P2093
Francis Ali-Osman
Gabriele Roehn
Hongjie Pan
Liangli Wang
Matthew Krantz
Robert D Pearlstein
Roland Goldbrunner
Wulf Paschen
P2860
P356
10.1111/CAS.12047
P577
2012-11-28T00:00:00Z